BIOPHARMA CREDIT PLC

Pre-Annual General Meeting Information • Apr 14, 2023

National Storage Mechanism | Additional information

RNS Number : 3179W

BioPharma Credit PLC

14 April 2023

14 April 2023

BioPharma Credit plc

(the "Company")

NOTICE OF ANNUAL GENERAL MEETING

Following the publication on 22 March 2023 of its Annual Financial Report for the year ended 31 December 2022, the Company announces that it will hold its Annual General Meeting ("AGM") at 1.00 p.m. on 30 May 2023 at the offices of Herbert Smith Freehills LLP, Exchange House, Primrose Street, London EC2A 2EG.

A copy of the Notice of the AGM is available to view on the Company's website at http://www.bpcruk.com. It has also been submitted to the National Storage Mechanism and is available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. Copies of the Notice of the AGM have been posted or made available to the Company's Shareholders.

Enquiries:

BioPharma Credit plc

via Link Company Matters Limited

Company Secretary

+44 (0) 333 300 1950

Notes to Editors:

BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

LEI: 213800AV55PYXAS7SY24 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOASFSFILEDSEFL